| Bioactivity | EGFRvIII peptide (PEPvIII) is a tumor-specific mutation that is widely expressed in glioblastoma multiforme (GBM) and other neoplasms and its expression enhances tumorigenicity. EGFRvIII peptide represents a truly tumor-specific target for antitumor immunotherapy[1]. |
| Name | EGFRvIII peptide (PEPvIII) |
| CAS | 129112-17-0 |
| Shortening | LEEKKGNYVVTDHC |
| Formula | C70H111N19O24S |
| Molar Mass | 1634.81 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
EGFRvIII peptide (PEPvIII)
CAS: 129112-17-0 F: C70H111N19O24S W: 1634.81
EGFRvIII peptide (PEPvIII) is a tumor-specific mutation that is widely expressed in glioblastoma multiforme (GBM) and ot
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.